|
1
|
Amé JC, Spenlehauer C and de Murcia G: The
PARP superfamily. Bioessays. 26:882–893. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cantó C, Sauve A and Bai P: Crosstalk
between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol
Aspects Med. 34:1168–201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartolomei G, Leutert M, Manzo M, Baubec T
and Hottiger MO: Analysis of chromatin ADP-ribosylation at the
genome-wide level and at specific loci by ADPr-ChAP. Mol Cell.
61:474–485. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gibson BA and Kraus WL: Identification of
protein substrates of specific PARP enzymes using analog-sensitive
PARP mutants and a ‘Clickable’ NAD+ analog. Methods Mol Biol.
1608:111–135. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schreiber V, Amé JC, Dollé P, Schultz I,
Rinaldi B, Fraulob V, Ménissier-de Murcia J and de Murcia G:
Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient
base excision DNA repair in association with PARP-1 and XRCC1. J
Biol Chem. 277:23028–23036. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bai P and Virág L: Role of
poly(ADP-ribose) polymerases in the regulation of inflammatory
processes. FEBS Lett. 586:3771–3777. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rosado MM, Bennici E, Novelli F and Pioli
C: Beyond DNA repair, the immunological role of PARP-1 and its
siblings. Immunology. 139:428–437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mangerich A and Bürkle A: Pleiotropic
cellular functions of PARP1 in longevity and aging: Genome
maintenance meets inflammation. Oxid Med Cell Longev.
2012:3216532012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oliver FJ, Ménissier-de Murcia J, Nacci C,
Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC
and de Murcia G: Resistance to endotoxic shock as a consequence of
defective NF-kappaB activation in poly(ADP-ribose) polymerase-1
deficient mice. EMBO J. 18:4446–4454. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Buzzo CL, Medina T, Branco LM, Lage SL,
Ferreira LC, Amarante-Mendes GP, Hottiger MO, De Carvalho DD and
Bortoluci KR: Epigenetic regulation of nitric oxide synthase 2,
inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage.
Sci Rep. 7:416862017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kiss B, Szántó M, Szklenár M, Brunyánszki
A, Marosvölgyi T, Sárosi E, Remenyik É, Gergely P, Virág L, Decsi
T, et al: Poly(ADP) ribose polymerase-1 ablation alters eicosanoid
and docosanoid signaling and metabolism in a murine model of
contact hypersensitivity. Mol Med Rep. 11:2861–2867. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cecchinato V and Uguccioni M: Insight on
the regulation of chemokine activities. J Leukoc Biol. Apr
18–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hughes CE and Nibbs RJB: A guide to
chemokines and their receptors. FEBS J. Apr 10–2018.(Epub ahead of
print). View Article : Google Scholar :
|
|
14
|
Zingarelli B, Szabó C and Salzman AL:
Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil
recruitment, oxidant generation, and mucosal injury in murine
colitis. Gastroenterology. 116:335–345. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin Y, Tang X, Zhu Y, Shu T and Han X:
Identification of PARP-1 as one of the transcription factors
binding to the repressor element in the promoter region of COX-2.
Arch Biochem Biophys. 505:123–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brunyánszki A, Hegedus C, Szántó M,
Erdélyi K, Kovács K, Schreiber V, Gergely S, Kiss B, Szabó E, Virág
L and Bai P: Genetic ablation of PARP-1 protects against
oxazolone-induced contact hypersensitivity by modulating oxidative
stress. J Invest Dermatol. 130:2629–2637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morrow DA, Brickman CM, Murphy SA, Baran
K, Krakover R, Dauerman H, Kumar S, Slomowitz N, Grip L, McCabe CH
and Salzman AL: A randomized, placebo-controlled trial to evaluate
the tolerability, safety, pharmacokinetics, and pharmacodynamics of
a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in
patients with ST-elevation myocardial infarction undergoing primary
percutaneous coronary intervention: Results of the TIMI 37 trial. J
Thromb Thrombolysis. 27:359–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mikó E, Vida A and Bai P: Translational
aspects of the microbiome-to be exploited. Cell Biol Toxicol.
32:153–156. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Del Vecchio F, Mastroiaco V, Di Marco A,
Compagnoni C, Capece D, Zazzeroni F, Capalbo C, Alesse E and
Tessitore A: Next-generation sequencing: Recent applications to the
analysis of colorectal cancer. J Transl Med. 15:2462017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Quince C, Walker AW, Simpson JT, Loman NJ
and Segata N: Shotgun metagenomics, from sampling to analysis. Nat
Biotechnol. 35:833–844. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shaffer M, Armstrong AJS, Phelan VV,
Reisdorph N and Lozupone CA: Microbiome and metabolome data
integration provides insight into health and disease. Transl Res.
189:51–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reuter JA, Spacek DV and Snyder MP:
High-throughput sequencing technologies. Mol Cell. 58:586–597.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tlaskalová-Hogenová H, Stěpánková R,
Kozáková H, Hudcovic T, Vannucci L, Tučková L, Rossmann P, Hrnčíř
T, Kverka M, Zákostelská Z, et al: The role of gut microbiota
(commensal bacteria) and the mucosal barrier in the pathogenesis of
inflammatory and autoimmune diseases and cancer: Contribution of
germ-free and gnotobiotic animal models of human diseases. Cell Mol
Immunol. 8:110–120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kahn SE, Cooper ME and Del Prato S:
Pathophysiology and treatment of type 2 diabetes: Perspectives on
the past, present, and future. Lancet. 383:1068–1083. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Naseer MI, Bibi F, Alqahtani MH, Chaudhary
AG, Azhar EI, Kamal MA and Yasir M: Role of gut microbiota in
obesity, type 2 diabetes and Alzheimer's disease. CNS Neurol Disord
Drug Targets. 13:305–311. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Puertollano E, Kolida S and Yaqoob P:
Biological significance of short-chain fatty acid metabolism by the
intestinal microbiome. Curr Opin Clin Nutr Metab Care. 17:139–144.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duca FA, Sakar Y, Lepage P, Devime F,
Langelier B, Doré J and Covasa M: Replication of obesity and
associated signaling pathways through transfer of microbiota from
obese prone rat. Diabetes. 63:1624–1636. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie G, Wang X, Huang F, Zhao A, Chen W,
Yan J, Zhang Y, Lei S, Ge K, Zheng X, et al: Dysregulated hepatic
bile acids collaboratively promote liver carcinogenesis. Int J
Cancer. 139:1764–1775. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshimoto S, Loo TM, Atarashi K, Kanda H,
Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et
al: Obesity-induced gut microbial metabolite promotes liver cancer
through senescence secretome. Nature. 499:97–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leifer CA, McConkey C, Li S, Chassaing B,
Gewirtz AT and Ley RE: Linking genetic variation in human Toll-like
receptor 5 genes to the gut microbiome's potential to cause
inflammation. Immunol Lett. 162:3–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Velloso LA, Folli F and Saad MJ: TLR4 at
the crossroads of nutrients, gut microbiota, and metabolic
inflammation. Endocr Rev. 36:245–271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Caballero S and Pamer EG:
Microbiota-mediated inflammation and antimicrobial defense in the
intestine. Annu Rev Immunol. 33:227–256. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goedert JJ, Jones G, Hua X, Xu X, Yu G,
Flores R, Falk RT, Gail MH, Shi J, Ravel J and Feigelson HS:
Investigation of the association between the fecal microbiota and
breast cancer in postmenopausal women: A population-based
case-control pilot study. J Natl Cancer Inst. 107:djv1472015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mu C, Yang Y and Zhu W: Crosstalk between
the immune receptors and gut microbiota. Curr Protein Pept Sci.
16:622–631. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Frosali S, Pagliari D, Gambassi G,
Landolfi R, Pandolfi F and Cianci R: How the intricate interaction
among toll-like receptors, microbiota, and intestinal immunity can
influence gastrointestinal pathology. J Immunol Res.
2015:4898212015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Farez MF, Quintana FJ, Gandhi R, Izquierdo
G, Lucas M and Weiner HL: Toll-like receptor 2 and poly(ADP-ribose)
polymerase 1 promote central nervous system neuroinflammation in
progressive EAE. Nat Immunol. 10:958–964. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zerfaoui M, Errami Y, Naura AS, Suzuki Y,
Kim H, Ju J, Liu T, Hans CP, Kim JG, Abd Elmageed ZY, et al:
Poly(ADP-ribose) polymerase-1 is a determining factor in
Crm1-mediated nuclear export and retention of p65 NF-kappa B upon
TLR4 stimulation. J Immunol. 185:1894–1902. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kauppinen A, Suuronen T, Ojala J,
Kaarniranta K and Salminen A: Antagonistic crosstalk between NF-κB
and SIRT1 in the regulation of inflammation and metabolic
disorders. Cell Signal. 25:1939–1948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Krukenberg KA, Kim S, Tan ES, Maliga Z and
Mitchison TJ: Extracellular poly(ADP-ribose) is a pro-inflammatory
signal for macrophages. Chem Biol. 22:446–452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qin WD, Mi SH, Li C, Wang GX, Zhang JN,
Wang H, Zhang F, Ma Y, Wu DW and Zhang M: Low shear stress induced
HMGB1 translocation and release via PECAM-1/PARP-1 pathway to
induce inflammation response. PLoS One. 10:e01205862015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Menissier-de Murcia J, Niedergang C,
Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M,
Dierich A, LeMeur M, et al: Requirement of poly(ADP-ribose)
polymerase in recovery from DNA damage in mice and in cells.
ProcNatl Acad Sci USA. 94:7303–7307. 1997. View Article : Google Scholar
|
|
42
|
Meyer F, Paarmann D, D'Souza M, Olson R,
Glass EM, Kubal M, Paczian T, Rodriguez A, Stevens R, Wilke A, et
al: The metagenomics RAST server-a public resource for the
automatic phylogenetic and functional analysis of metagenomes. BMC
Bioinformatics. 9:3862008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hammer O, Harper DAT and Ryan PD: PAST:
Paleontological statistics software package for education and data
analysis. Palaeontologia Electronica. 4:92001.
|
|
44
|
Newcombe RG: Two-sided confidence
intervals for the single proportion: Comparison of seven methods.
Stat Med. 17:857–872. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Newcombe RG: Interval estimation for the
difference between independent proportions: Comparison of eleven
methods. Stat Med. 17:873–890. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tothmeresz B: Comparison of different
methods for diversity ordering. J Veget Sci. 6:283–290. 1995.
View Article : Google Scholar
|
|
47
|
Larmonier CB, Shehab KW, Laubitz D, Jamwal
DR, Ghishan FK and Kiela PR: Transcriptional reprogramming and
resistance to colonic mucosal injury in Poly(ADP-ribose) Polymerase
1 (PARP1)-deficient mice. J Biol Chem. 291:8918–8930. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lagkouvardos I, Pukall R, Abt B, Foesel
BU, Meier-Kolthoff JP, Kumar N, Bresciani A, Martínez I, Just S,
Ziegler C, et al: The mouse intestinal bacterial collection (miBC)
provides host-specific insight into cultured diversity and
functional potential of the gut microbiota. Nat Microbiol.
1:161312016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Davis K, Banerjee S, Friggeri A, Bell C,
Abraham E and Zerfaoui M: Poly(ADP-ribosyl)ation of high mobility
group box 1 (HMGB1) protein enhances inhibition of efferocytosis.
Mol Med. 18:359–369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Szanto M, Rutkai I, Hegedus C, Czikora Á,
Rózsahegyi M, Kiss B, Virág L, Gergely P, Tóth A and Bai P:
Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced
damage through SIRT1 induction. Cardiovasc Res. 92:430–438. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bai P, Canto C, Brunyánszki A, Huber A,
Szántó M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H, et al:
PARP-2 regulates sirt1 expression and whole-body energy
expenditure. Cell Metab. 13:450–460. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pascual M, López-Nevot MA, Cáliz R, Ferrer
MA, Balsa A, Pascual-Salcedo D and Martín J: A poly(ADP-ribose)
polymerase haplotype spanning the promoter region confers
susceptibility to rheumatoid arthritis. Arthritis Rheum.
48:638–641. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Masutani M, Nakagama H and Sugimura T:
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune
disease. Cell Mol Life Sci. 62:769–783. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Burkart V, Wang ZQ, Radons J, Heller B,
Herceg Z, Stingl L, Wagner EF and Kolb H: Mice lacking the
poly(ADP-ribose) polymerase gene are resistant to pancreatic
beta-cell destruction and diabetes development induced by
streptozocin. Nat Med. 5:314–319. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pacher P, Beckman JS and Liaudet L: Nitric
oxide and peroxynitrite in health and disease. Physiol Rev.
87:315–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bai P, Cantó C, Oudart H, Brunyánszki A,
Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, et al:
PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1
Activation. Cell Metab. 13:461–468. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Koren O, Goodrich JK, Cullender TC, Spor
A, Laitinen K, Bäckhed HK, Gonzalez A, Werner JJ, Angenent LT,
Knight R, et al: Host remodeling of the gut microbiome and
metabolic changes during pregnancy. Cell. 150:470–480. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Le Chatelier E, Nielsen T, Qin J, Prifti
E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy
S, et al: Richness of human gut microbiome correlates with
metabolic markers. Nature. 500:541–546. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kamvissi-Lorenz V, Raffaelli M, Bornstein
S and Mingrone G: Role of the Gut on glucose homeostasis: Lesson
learned from metabolic surgery. Curr Atheroscler Rep. 19:92017.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fong PC, Boss DS, Yap TA, Tutt A, Wu P,
Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, et
al: Inhibition of Poly(ADP-Ribose) polymerase in tumors from BRCA
mutation carriers. N Engl J Med. 361:123–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
